Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.72 +0.23 (+2.37%)
As of: Nov 11, 2026 · 1:44 PM EST

Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025)

Updated

Analysis

Syndax Pharmaceuticals (SNDX) Capital Expenditures (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 56,000.00
Sep 30, 2025 131,000.00
Dec 31, 2018 14,000.00
Mar 31, 2018 173,000.00
Dec 31, 2017 42,000.00
Sep 30, 2016 55,000.00
Jun 30, 2016 73,000.00
Mar 31, 2016 133,000.00
Dec 31, 2015 31,000.00
Sep 30, 2015 13,000.00
API Access

Syndax Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SNDX&period=max&api_key=YOUR_API_KEY